Unity Biotechnology Stock Market Value
| UBX Stock | USD 2.22 0.08 3.74% |
| Symbol | Unity |
Unity Biotechnology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Unity Biotechnology. If investors know Unity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Unity Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Unity Biotechnology is measured differently than its book value, which is the value of Unity that is recorded on the company's balance sheet. Investors also form their own opinion of Unity Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Unity Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Unity Biotechnology's market value can be influenced by many factors that don't directly affect Unity Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Unity Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Unity Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unity Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Unity Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Unity Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Unity Biotechnology.
| 02/08/2024 |
| 02/02/2025 |
If you would invest 0.00 in Unity Biotechnology on February 8, 2024 and sell it all today you would earn a total of 0.00 from holding Unity Biotechnology or generate 0.0% return on investment in Unity Biotechnology over 360 days. Unity Biotechnology is related to or competes with Recursion Pharmaceuticals, Atea Pharmaceuticals, Hookipa Pharma, Acumen Pharmaceuticals, Heron Therapeuti, Avidity Biosciences, and Beam Therapeutics. Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, hal... More
Unity Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Unity Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Unity Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.88 | |||
| Information Ratio | 0.117 | |||
| Maximum Drawdown | 65.58 | |||
| Value At Risk | (7.39) | |||
| Potential Upside | 16.76 |
Unity Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Unity Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Unity Biotechnology's standard deviation. In reality, there are many statistical measures that can use Unity Biotechnology historical prices to predict the future Unity Biotechnology's volatility.| Risk Adjusted Performance | 0.1145 | |||
| Jensen Alpha | 1.2 | |||
| Total Risk Alpha | 0.386 | |||
| Sortino Ratio | 0.1798 | |||
| Treynor Ratio | (1.02) |
Unity Biotechnology Backtested Returns
Unity Biotechnology is dangerous given 3 months investment horizon. Unity Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. We have analyzed twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.33% are justified by taking the suggested risk. Use Unity Biotechnology Semi Deviation of 5.12, coefficient of variation of 795.28, and Risk Adjusted Performance of 0.1145 to evaluate company specific risk that cannot be diversified away. Unity Biotechnology holds a performance score of 11 on a scale of zero to a hundred. The entity has a beta of -1.1, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Unity Biotechnology are expected to decrease slowly. On the other hand, during market turmoil, Unity Biotechnology is expected to outperform it slightly. Use Unity Biotechnology maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Unity Biotechnology.
Auto-correlation | 0.14 |
Insignificant predictability
Unity Biotechnology has insignificant predictability. Overlapping area represents the amount of predictability between Unity Biotechnology time series from 8th of February 2024 to 6th of August 2024 and 6th of August 2024 to 2nd of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Unity Biotechnology price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Unity Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Unity Biotechnology lagged returns against current returns
Autocorrelation, which is Unity Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Unity Biotechnology's stock expected returns. We can calculate the autocorrelation of Unity Biotechnology returns to help us make a trade decision. For example, suppose you find that Unity Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Unity Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Unity Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Unity Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Unity Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Unity Biotechnology Lagged Returns
When evaluating Unity Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Unity Biotechnology stock have on its future price. Unity Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Unity Biotechnology autocorrelation shows the relationship between Unity Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Unity Biotechnology.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.